Search research articles
Contact Us
Filters
Showing results (51-60 of 85) with videos related to
Page
of 9
Sort By:
American Journal of Hematology
|
August 29, 2025
Impact of Donor Type on Outcomes After Allogeneic Hematopoietic Cell Transplantation in Myelofibrosis: A Study on Behalf of the Chronic Malignancies Working Party of the EBMT
Juan Carlos Hernández-Boluda, Vipul Sheth, Simona Iacobelli, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
January 18, 2018
Incidence of Second Primary Malignancies after Autologous Transplantation for Multiple Myeloma in the Era of Novel Agents
Firoozeh Sahebi, Simona Iacobelli, Giulia Sbianchi, et al.
Bone Marrow Transplantation
|
December 2, 2021
Impact of donor-derived CD34 + infused cell dose on outcomes of patients undergoing allo-HCT following reduced intensity regimen for myelofibrosis: a study from the Chronic Malignancies Working Party of the EBMT
Tomasz Czerw, Simona Iacobelli, Vittoria Malpassuti, et al.
Bone Marrow Transplantation
|
July 30, 2025
Outcomes following different upfront stem cell transplantation strategies for multiple myeloma: a statistical perspective on behalf of the Chronic Malignancies Working Party of the EBMT
Simona Iacobelli, Stefan Schönland, Linda Koster, et al.
Bone Marrow Transplantation
|
June 14, 2023
Correction: An early post-transplant relapse prediction score in multiple myeloma: a large cohort study from the chronic malignancies working party of EBMT
Meral Beksac, Simona Iacobelli, Linda Koster, et al.
Bone Marrow Transplantation
|
March 30, 2022
Prognostic value of a new clinically-based classification system in patients with CMML undergoing allogeneic HCT: a retrospective analysis of the EBMT-CMWP
Francesco Onida, Giulia Sbianchi, Aleksandar Radujkovic, et al.
Bone Marrow Transplantation
|
May 10, 2023
An early post-transplant relapse prediction score in multiple myeloma: a large cohort study from the chronic malignancies working party of EBMT
Meral Beksac, Simona Iacobelli, Linda Koster, et al.
Haematologica
|
December 9, 2017
Melphalan 140 mg/m<sup>2</sup> or 200 mg/m<sup>2</sup> for autologous transplantation in myeloma: results from the Collaboration to Collect Autologous Transplant Outcomes in Lymphoma and Myeloma (CALM) study. A report by the EBMT Chronic Malignancies Working Party
Holger W Auner, Simona Iacobelli, Giulia Sbianchi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 20, 2016
Impact of Donor Epstein-Barr Virus Serostatus on the Incidence of Graft-Versus-Host Disease in Patients With Acute Leukemia After Hematopoietic Stem-Cell Transplantation: A Study From the Acute Leukemia and Infectious Diseases Working Parties of the European Society for Blood and Marrow Transplantation
Jan Styczynski, Gloria Tridello, Lidia Gil, et al.
European Journal of Haematology
|
February 13, 2021
Prognostic impact of early-versus-late responses to different induction regimens in patients with myeloma undergoing autologous hematopoietic cell transplantation: Results from the CALM study by the CMWP of the EBMT
Laurent Garderet, Giulia Sbianchi, Simona Iacobelli, et al.
Page
of 9
Search research articles
Search
Showing results (51-60 of 85) with videos related to
Sort By:
Page
of 9
American Journal of Hematology
|
August 29, 2025
Impact of Donor Type on Outcomes After Allogeneic Hematopoietic Cell Transplantation in Myelofibrosis: A Study on Behalf of the Chronic Malignancies Working Party of the EBMT
Juan Carlos Hernández-Boluda, Vipul Sheth, Simona Iacobelli, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
January 18, 2018
Incidence of Second Primary Malignancies after Autologous Transplantation for Multiple Myeloma in the Era of Novel Agents
Firoozeh Sahebi, Simona Iacobelli, Giulia Sbianchi, et al.
Bone Marrow Transplantation
|
December 2, 2021
Impact of donor-derived CD34 + infused cell dose on outcomes of patients undergoing allo-HCT following reduced intensity regimen for myelofibrosis: a study from the Chronic Malignancies Working Party of the EBMT
Tomasz Czerw, Simona Iacobelli, Vittoria Malpassuti, et al.
Bone Marrow Transplantation
|
July 30, 2025
Outcomes following different upfront stem cell transplantation strategies for multiple myeloma: a statistical perspective on behalf of the Chronic Malignancies Working Party of the EBMT
Simona Iacobelli, Stefan Schönland, Linda Koster, et al.
Bone Marrow Transplantation
|
June 14, 2023
Correction: An early post-transplant relapse prediction score in multiple myeloma: a large cohort study from the chronic malignancies working party of EBMT
Meral Beksac, Simona Iacobelli, Linda Koster, et al.
Bone Marrow Transplantation
|
March 30, 2022
Prognostic value of a new clinically-based classification system in patients with CMML undergoing allogeneic HCT: a retrospective analysis of the EBMT-CMWP
Francesco Onida, Giulia Sbianchi, Aleksandar Radujkovic, et al.
Bone Marrow Transplantation
|
May 10, 2023
An early post-transplant relapse prediction score in multiple myeloma: a large cohort study from the chronic malignancies working party of EBMT
Meral Beksac, Simona Iacobelli, Linda Koster, et al.
Haematologica
|
December 9, 2017
Melphalan 140 mg/m<sup>2</sup> or 200 mg/m<sup>2</sup> for autologous transplantation in myeloma: results from the Collaboration to Collect Autologous Transplant Outcomes in Lymphoma and Myeloma (CALM) study. A report by the EBMT Chronic Malignancies Working Party
Holger W Auner, Simona Iacobelli, Giulia Sbianchi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 20, 2016
Impact of Donor Epstein-Barr Virus Serostatus on the Incidence of Graft-Versus-Host Disease in Patients With Acute Leukemia After Hematopoietic Stem-Cell Transplantation: A Study From the Acute Leukemia and Infectious Diseases Working Parties of the European Society for Blood and Marrow Transplantation
Jan Styczynski, Gloria Tridello, Lidia Gil, et al.
European Journal of Haematology
|
February 13, 2021
Prognostic impact of early-versus-late responses to different induction regimens in patients with myeloma undergoing autologous hematopoietic cell transplantation: Results from the CALM study by the CMWP of the EBMT
Laurent Garderet, Giulia Sbianchi, Simona Iacobelli, et al.
Page
of 9